Lowering the risk of esophagitis from alendronate therapy.
Chase
J L
JL
Pharmacy Department, Boston Medical Center, MA 02118, USA. jennifer.chase@bmc.org
D019386:Alendronate / Q000008:administration & dosage* / Q000009:adverse effects; D004941:Esophagitis / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy
D019386:Alendronate